279 related articles for article (PubMed ID: 19398707)
21. N-acetylaspartate, choline, myoinositol, glutamine and glutamate (glx) concentration changes in proton MR spectroscopy (1H MRS) in patients with mild cognitive impairment (MCI).
Walecki J; Barcikowska M; Ćwikła JB; Gabryelewicz T
Med Sci Monit; 2011 Dec; 17(12):MT105-11. PubMed ID: 22129910
[TBL] [Abstract][Full Text] [Related]
22. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI.
Jessen F; Gür O; Block W; Ende G; Frölich L; Hammen T; Wiltfang J; Kucinski T; Jahn H; Heun R; Maier W; Kölsch H; Kornhuber J; Träber F
Neurology; 2009 May; 72(20):1735-40. PubMed ID: 19451528
[TBL] [Abstract][Full Text] [Related]
23. Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
Weiss U; Bacher R; Vonbank H; Kemmler G; Lingg A; Marksteiner J
J Clin Psychiatry; 2003 Mar; 64(3):235-42. PubMed ID: 12716263
[TBL] [Abstract][Full Text] [Related]
24. Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment.
van de Pol LA; van der Flier WM; Korf ES; Fox NC; Barkhof F; Scheltens P
Neurology; 2007 Oct; 69(15):1491-7. PubMed ID: 17923611
[TBL] [Abstract][Full Text] [Related]
25. Using proton magnetic resonance spectroscopy to identify mild cognitive impairment.
Wang T; Xiao S; Li X; Ding B; Ling H; Chen K; Fang Y
Int Psychogeriatr; 2012 Jan; 24(1):19-27. PubMed ID: 21676281
[TBL] [Abstract][Full Text] [Related]
26. Volumetric MRI and 1H MRS study of hippocampus in unilateral MCAO patients: relationship between hippocampal secondary damage and cognitive disorder following stroke.
Tang X; Wang C; Xia L; Zhu W; Zhao L; Zhu W
Eur J Radiol; 2012 Oct; 81(10):2788-93. PubMed ID: 21945401
[TBL] [Abstract][Full Text] [Related]
27. Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study.
Waragai M; Moriya M; Nojo T
J Alzheimers Dis; 2017; 60(4):1411-1427. PubMed ID: 28968236
[TBL] [Abstract][Full Text] [Related]
28. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
29. A decrease in N-acetylaspartate and an increase in myoinositol in the anterior cingulate gyrus are associated with behavioral and psychological symptoms in Alzheimer's disease.
Shinno H; Inagaki T; Miyaoka T; Okazaki S; Kawamukai T; Utani E; Inami Y; Horiguchi J
J Neurol Sci; 2007 Sep; 260(1-2):132-8. PubMed ID: 17540407
[TBL] [Abstract][Full Text] [Related]
30. Longitudinal volumetric MRI change and rate of cognitive decline.
Mungas D; Harvey D; Reed BR; Jagust WJ; DeCarli C; Beckett L; Mack WJ; Kramer JH; Weiner MW; Schuff N; Chui HC
Neurology; 2005 Aug; 65(4):565-71. PubMed ID: 16116117
[TBL] [Abstract][Full Text] [Related]
31. 1H magnetic resonance spectroscopy, cognitive function, and apolipoprotein E genotype in normal aging, mild cognitive impairment and Alzheimer's disease.
Kantarci K; Smith GE; Ivnik RJ; Petersen RC; Boeve BF; Knopman DS; Tangalos EG; Jack CR
J Int Neuropsychol Soc; 2002 Nov; 8(7):934-42. PubMed ID: 12405545
[TBL] [Abstract][Full Text] [Related]
32. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia.
Smith EE; Egorova S; Blacker D; Killiany RJ; Muzikansky A; Dickerson BC; Tanzi RE; Albert MS; Greenberg SM; Guttmann CR
Arch Neurol; 2008 Jan; 65(1):94-100. PubMed ID: 18195145
[TBL] [Abstract][Full Text] [Related]
33. Comparative diagnostic utility of different MR modalities in mild cognitive impairment and Alzheimer's disease.
Kantarci K; Xu Y; Shiung MM; O'Brien PC; Cha RH; Smith GE; Ivnik RJ; Boeve BF; Edland SD; Kokmen E; Tangalos EG; Petersen RC; Jack CR
Dement Geriatr Cogn Disord; 2002; 14(4):198-207. PubMed ID: 12411762
[TBL] [Abstract][Full Text] [Related]
34. Elevated brain scyllo-inositol concentrations in patients with Alzheimer's disease.
Griffith HR; den Hollander JA; Stewart CC; Evanochko WT; Buchthal SD; Harrell LE; Zamrini EY; Brockington JC; Marson DC
NMR Biomed; 2007 Dec; 20(8):709-16. PubMed ID: 17295394
[TBL] [Abstract][Full Text] [Related]
35. Proton MRS in mild cognitive impairment.
Kantarci K
J Magn Reson Imaging; 2013 Apr; 37(4):770-7. PubMed ID: 23526756
[TBL] [Abstract][Full Text] [Related]
36. Clinical predictors of cognitive decline in patients with mild cognitive impairment: the Chongqing aging study.
Li L; Wang Y; Yan J; Chen Y; Zhou R; Yi X; Shi Q; Zhou H;
J Neurol; 2012 Jul; 259(7):1303-11. PubMed ID: 22186849
[TBL] [Abstract][Full Text] [Related]
37. Brain myoinositol as a potential marker of amyloid-related pathology: A longitudinal study.
Voevodskaya O; Poulakis K; Sundgren P; van Westen D; Palmqvist S; Wahlund LO; Stomrud E; Hansson O; Westman E;
Neurology; 2019 Jan; 92(5):e395-e405. PubMed ID: 30610093
[TBL] [Abstract][Full Text] [Related]
38. Correlation of auditory event-related potentials and magnetic resonance spectroscopy measures in mild cognitive impairment.
Li X; Shao X; Wang N; Wang T; Chen G; Zhou H
Brain Res; 2010 Jul; 1346():204-12. PubMed ID: 20470761
[TBL] [Abstract][Full Text] [Related]
39. Hippocampal volumes predict risk of dementia with Lewy bodies in mild cognitive impairment.
Kantarci K; Lesnick T; Ferman TJ; Przybelski SA; Boeve BF; Smith GE; Kremers WK; Knopman DS; Jack CR; Petersen RC
Neurology; 2016 Nov; 87(22):2317-2323. PubMed ID: 27807186
[TBL] [Abstract][Full Text] [Related]
40. Proton spectroscopy in Alzheimer's disease and cognitive impairment no dementia: a community-based study.
Azevedo D; Tatsch M; Hototian SR; Bazzarella MC; Castro CC; Bottino CM
Dement Geriatr Cogn Disord; 2008; 25(6):491-500. PubMed ID: 18441524
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
